FDA Announces Submission of Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to risk management programs in pharmacy practice, which has been submitted to the Office of Management and Budget (OMB) for review and clearance.